The synchronous quantitative changes of CD44- and CD9-labeled epithelial layers of OL may be related to severe maturation disorders, which are critically important for clinicians and patients in the management of OPMD. The gene discussed is CD44; the disease is oculopharyngeal muscular dystrophy.